SOPHARMA AD - Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. 097900BGGW0000048796-20231231-EN-CON.zipPublication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 22 / 2024

Date of issue: 2024-04-25

Short name of the issuer

SOPHARMA AD

Subject

Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format., Notification for Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format., Annual consolidated audited financial report of "Sopharma" AD for 2023 in BFSC format

Annexes

File Description

097900BGGW0000048796-20231231-EN-CON.zip097900BGGW0000048796-20231231-EN-CON.zip Publication of Annual consolidated audited financial report of "Sopharma" AD for 2023 in ESF format

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2024-04-25 Ognian Donev Executive Director